OPTOMED OY A EO 005
Optomed Oyj, together with its subsidiaries, manufactures and sells handheld fundus cameras in Finland, rest of Europe, and internationally. The company operates in two segments, Devices and Software. It develops, manufactures, and sells fundus cameras for ophthalmologists, pediatricians, endocrinologists, neurologists, and primary health care professionals; and provides professional IT consultin… Read more
OPTOMED OY A EO 005 (36U0) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, OPTOMED OY A EO 005 (36U0) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
OPTOMED OY A EO 005 - Net Assets Trend (None–None)
This chart illustrates how OPTOMED OY A EO 005's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for OPTOMED OY A EO 005 (None–None)
The table below shows the annual net assets of OPTOMED OY A EO 005 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to OPTOMED OY A EO 005's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
OPTOMED OY A EO 005 Competitors by Market Cap
The table below lists competitors of OPTOMED OY A EO 005 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
FCN Banc Corp
PINK:FBVI
|
$36.21 Million |
|
Neometals Ltd
OTCQX:NMTAY
|
$36.21 Million |
|
PLANETREE INTL.DEV.HD-10
F:YUIA
|
$36.22 Million |
|
STEEL EXCHANGE INDIA LIMITED
NSE:STEELXIND
|
$36.22 Million |
|
ENTERA BIO IS-0000769
F:5DT
|
$36.20 Million |
|
Jinhui Shipping and Transportation Limited
PINK:JNSTF
|
$36.20 Million |
|
EdiliziAcrobatica S.p.A
PA:ALEAC
|
$36.20 Million |
|
Train Alliance Sweden AB (publ)
F:7EF
|
$36.20 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in OPTOMED OY A EO 005's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares OPTOMED OY A EO 005's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently OPTOMED OY A EO 005 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares OPTOMED OY A EO 005's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $1,807,324,866
- Average return on equity (ROE) among peers: -12.22%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| OPTOMED OY A EO 005 (36U0) | €- | N/A | N/A | $36.21 Million |
| Schrödinger, Inc. (43Z) | $557.09 Million | -18.02% | 0.36x | $631.00 Million |
| DACHA STRATEGIC (7DC) | $40.24 Million | 0.65% | 0.08x | $81.97 Million |
| ABL Diagnostics Société anonyme (9BK0) | $6.77 Million | 0.80% | 1.20x | $371.65K |
| Zhejiang Taimei Medical Technology Co., Ltd. (A2V) | $1.04 Billion | -33.28% | 0.39x | $47.71 Million |
| ASCOM HLDG NA SF 0,50 (AH2N) | $80.00 Million | 16.88% | 1.43x | $190.62 Million |
| DocCheck AG (AJ91) | $18.14 Million | 3.32% | 0.15x | $18.00 Million |
| EM Systems Co. Ltd (EMO) | $17.69 Billion | 7.87% | 0.33x | $74.55 Million |
| Tempus AI (F3M) | $-1.38 Billion | 0.00% | 0.00x | $4.75 Billion |
| Pangenomic Health Inc. (LL3) | $2.24 Million | -118.14% | 0.15x | $4.82 Million |
| MeVis Medical Solutions AG (M3V) | $17.83 Million | 17.76% | 0.45x | $12.89 Million |